Archived Press Releases







Press Releases

1.05.2010

MonoSol Rx and Strativa Pharmaceuticals Extend Strategic Relationship

7.23.2009

MonoSol Rx Appoints Theodore Clemente Vice President Business Development

6.10.2009

MonoSol Rx Announces FDA Acceptance of NDA for Ondansetron Orally Dissolving Film Strip

4.09.2009

MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip

4.03.2009

MonoSol Rx Granted U.S. Article of Manufacture Patent

3.12.2009

MonoSol Rx Achieves Milestones for Additional $2.5 Million Private Debt Financing

3.12.2009

MonoSol Rx to Present at Cowen & Company 29th Annual Health Care Conference

12.16.2008

MonoSol Rx Enters Agreement with Hikma Pharmaceuticals PLC for Thin Film Pharmaceutical Products in the Middle East

12.02.2008

MonoSol Rx Successfully Completes Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA

11.26.2008

MonoSol Rx to Present at the 20th Annual Piper Jaffray Health Care Conference

11.03.2008

MonoSol Rx and Midatech Group Enter Collaboration Agreement to Unite Nanoparticle and Thin Film Drug Delivery Technologies

10.13.2008

Drug-delivery tech firms find bright spot in the economy

9.25.2008

MonoSol Rx Closes $20 Million in Private Equity Financing

9.11.2008

MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process

8.04.2008

MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Bioequivalence Study

6.17.2008
MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals, a Division of Par Pharmaceutical

6.12.2008
MonoSol Rx Closes $10 Million in Private Debt Financing

6.05.2008
MonoSol Rx Names Vincent Viviani Senior Vice President, Manufacturing and Operations

5.28.2008
MonoSol Rx Appoints John McCracken Senior Vice President Business Development

4.15.2008
MonoSol Rx, LLC granted US patent for thin film manufacturing process

2.21.2008
MonoSol Rx, LLC completes thin film ondansetron pilot bioequivalence study

3.27.2007
MonoSol Rx, LLC enters into a license and collaboration agreement with Adams Respiratory Therapuetics

12.12.2006
MonoSolRx Closes $38 Million Preferred Equity Investment

9.22.2006
MonoSolRx to Present at the UBS Global Life Sciences Conference

7.24.2006
MonoSolRx Announces Hiring of Keith Kendall as Chief Financial Officer

7.06.2006
MonoSol Rx Completes Successful DEA Registration of Both Its Manufacturing Facility and Development Facility

6.06.2006
MonoSol Rx Completes Analytical Laboratories to Support Film Based Drug Development and Manufacturing

5.22.2006
MonoSol Rx Announces Legal Settlement With Novartis Consumer Health Relating...

 

The information contained in these releases was current on the date the releases were issued and will become outdated over time. MonoSol Rx does not assume any responsibility for updating information in these releases.